• 
  F. Pommeret, J. Colomba, C. Bigenwald, A. Laparra, S. Bockel, et al.. Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies. Annals of Oncology, 2021, 32 (11), pp.1445--1447. ⟨10.1016/j.annonc.2021.07.015⟩. ⟨hal-03793520⟩
• 
  Charles Herbaux, Caroline Bret, Emmanuel Bachy, Pierre Bories, Roberta Di Blasi, et al.. Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.. Haematologica, 2024, Haematologica, ⟨10.3324/haematol.2023.284786⟩. ⟨hal-04689105⟩
• 
  Claire Michel, Marie Robin, Stephane Morisset, Didier Blaise, Johan Maertens, et al.. Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplantation, 2023, Bone Marrow Transplantation, 58 (5), pp.534-543. ⟨10.1038/s41409-023-01931-7⟩. ⟨hal-04672661⟩
• 
  Patricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, Christine Chevreau, Nicolas Penel, et al.. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.. Lancet Oncology, 2022, Lancet Oncology, 23 (8), pp.1044-1054. ⟨10.1016/S1470-2045(22)00380-1⟩. ⟨hal-04387055⟩
• 
  Hélène Tubeuf, Sandrine M Caputo, Teresa Sullivan, Julie Rondeaux, Sophie Krieger, et al.. Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System. Cancer Research, 2020, 80 (17), pp.3593-3605. ⟨10.1158/0008-5472.CAN-20-0895⟩. ⟨hal-03597164⟩
• 
  Justin Loke, Myriam Labopin, Charles Craddock, Gérard Socié, Tobias Gedde-Dahl, et al.. Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.. Cancer, 2024, Cancer, 130, pp.2642-2651. ⟨10.1002/cncr.35308⟩. ⟨hal-04672868⟩
• 
  Guy Gorochov, Jacques Ropers, Odile Launay, Karim Dorgham, Omaira da Mata-Jardin, et al.. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination. JAMA Network Open, 2024, 7 (4), pp.e248051. ⟨10.1001/jamanetworkopen.2024.8051⟩. ⟨hal-04669127⟩
• 
  Julien Guérin, Amine Nahid, Louis Tassy, Marc Deloger, François Bocquet, et al.. Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research. International Journal of Environmental Research and Public Health, 2024, 21 (2), pp.189. ⟨10.3390/ijerph21020189⟩. ⟨inserm-04659888⟩
• 
  J.Y. Blay, N. Penel, T. Valentin, P. Anract, F. Duffaud, et al.. Improved nationwide survival of sarcoma patients with a network of reference centers. Annals of Oncology, 2024, 35 (4), pp.351-363. ⟨10.1016/j.annonc.2024.01.001⟩. ⟨inserm-04658953⟩
• 
  Celine Bourgier, Didier Cowen, Florence Castan, Claire Lemanski, Sophie Gourgou, et al.. Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ. Radiotherapy & Oncology, 2021, 164, pp.57-65. ⟨10.1016/j.radonc.2021.09.014⟩. ⟨hal-04514163⟩
• 
  A. Le Cesne, J. Y. Blay, D. Cupissol, A. Italiano, C. Delcambre, et al.. A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial. Annals of Oncology, 2021, Annals of Oncology, 32 (8), p. 1034-1044. ⟨10.1016/j.annonc.2021.04.014⟩. ⟨hal-04522981⟩
• 
  Lucia Carril-Ajuria, Emeline Colomba, Luigi Cerbone, Carmen Romero-Ferreiro, Laurence Crouzet, et al.. Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma. European Journal of Cancer, 2021, 151, pp.106-114. ⟨10.1016/j.ejca.2021.04.009⟩. ⟨hal-04242389⟩
• 
  Laia Richart, Mary-Loup Picod-Chedotel, Michel Wassef, Manon Macario, Setareh Aflaki, et al.. XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation. Cell, 2022, 185 (12), pp.2164-2183.e25. ⟨10.1016/j.cell.2022.04.034⟩. ⟨hal-03951681⟩
• 
  Alice Mogenet, Fabrice Barlesi, Benjamin Besse, Stefan Michiels, Maryam Karimi, et al.. Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome. Lung Cancer, 2022, 169, pp.31-39. ⟨10.1016/j.lungcan.2022.05.004⟩. ⟨hal-03925563⟩
• 
  S. Henno, C. Jeanne, T de la Motte Rouge, C. Genestie, I. Treilleux, et al.. Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG). Gynecologic Oncology, 2022, 165 (3), pp.637-641. ⟨10.1016/j.ygyno.2022.03.019⟩. ⟨hal-03857604⟩
• 
  A. Moya-Plana, L. Tselikas, O. Lambotte, S. Temam, T. de Baere, et al.. Postgraduate oncology educational shifts during the COVID-19 pandemic: results of faculty and medical student surveys. ESMO OPEN, 2022, 7 (2), ⟨10.1016/j.esmoop.2022.100451⟩. ⟨hal-04085316⟩
• 
  Nicolas André, Marie Cécile Le Deley, Clémence Léguillette, Alicia Probst, Leen Willems, et al.. METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors. European Journal of Cancer, 2024, 198, pp.113525. ⟨10.1016/j.ejca.2024.113525⟩. ⟨hal-04653328⟩
• 
  Lyria Amari, Pascale Tomasini, Emmanuelle Dantony, Gaëlle Rousseau-Bussac, Charles Ricordel, et al.. Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study). Lung Cancer, 2024, 193, pp.107843. ⟨10.1016/j.lungcan.2024.107843⟩. ⟨hal-04652518⟩
• 
  Gael S. Roth, Loic Verlingue, Matthieu Sarabi, Jean Frédéric Blanc, Emmanuel Boleslawski, et al.. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT). European Journal of Cancer, 2024, 202, pp.114000. ⟨10.1016/j.ejca.2024.114000⟩. ⟨hal-04626861⟩
• 
  Caroline Hoffmann, Floriane Noel, Maximilien Grandclaudon, Lucile Massenet-Regad, Paula Michea, et al.. PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity. Nature Communications, 2022, 13 (1), pp.1983. ⟨10.1038/s41467-022-29516-w⟩. ⟨hal-03989545⟩

358

370